Relevance of Echocardiography-derived Phenotyping in Patients with Pulmonary Arterial Hypertension Treated with Initial Oral Combination Therapy: An Italian Pulmonary Hypertension Network (iPHNET) Study
- 1 August 2024
- journal article
- letter
- Published by Oxford University Press (OUP) in American Journal of Respiratory and Critical Care Medicine
- Vol. 210 (3) , 362-365
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Pathophysiology of the right ventricle in health and disease: an updateCardiovascular Research, 2023
- Interest of TAPSE/sPAP ratio for noninvasive pulmonary arterial hypertension risk assessmentThe Journal of Heart and Lung Transplantation, 2022
- COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertensionEuropean Respiratory Journal, 2021
- Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial HypertensionAmerican Journal of Respiratory and Critical Care Medicine, 2021
- Hemodynamics and risk assessment 2 years after the initiation of upfront ambrisentan‒tadalafil in pulmonary arterial hypertensionThe Journal of Heart and Lung Transplantation, 2020
- Clinical implications of idiopathic pulmonary arterial hypertension phenotypes defined by cluster analysisThe Journal of Heart and Lung Transplantation, 2020
- Predicting Survival in Patients With Pulmonary Arterial HypertensionChest, 2019
- Anatomy, Function, and Dysfunction of the Right VentricleJACC, 2019
- Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of EchocardiographyJournal of the American Society of Echocardiography, 2010